NCT06271369View on ClinicalTrials.gov

Real-World HRU and Costs in DLBCL Pts With Tisa-cel and Axi-cel, a Medicare Study.

CompletedOBSERVATIONAL
Enrollment

613

Participants

Timeline

Start Date

August 11, 2022

Primary Completion Date

February 15, 2023

Study Completion Date

February 15, 2023

Conditions
Diffuse Large B-cell Lymphoma
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY